PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 66 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,244,214 | +3.9% | 246,379 | +3.5% | 0.00% | – |
Q2 2023 | $1,197,890 | +285.2% | 238,149 | +371.0% | 0.00% | – |
Q1 2023 | $310,962 | -52.2% | 50,563 | +2.5% | 0.00% | – |
Q4 2022 | $651,169 | +378.8% | 49,331 | +7.8% | 0.00% | – |
Q3 2022 | $136,000 | -8.1% | 45,754 | +12.9% | 0.00% | – |
Q2 2022 | $148,000 | -42.9% | 40,514 | -3.1% | 0.00% | – |
Q1 2022 | $259,000 | -23.6% | 41,820 | 0.0% | 0.00% | – |
Q4 2021 | $339,000 | -42.2% | 41,820 | +6.3% | 0.00% | – |
Q3 2021 | $586,000 | +28.8% | 39,354 | +8.4% | 0.00% | – |
Q2 2021 | $455,000 | +175.8% | 36,293 | 0.0% | 0.00% | – |
Q1 2021 | $165,000 | +60.2% | 36,293 | -25.0% | 0.00% | – |
Q4 2020 | $103,000 | +243.3% | 48,417 | +276.4% | 0.00% | – |
Q3 2020 | $30,000 | +15.4% | 12,863 | -0.4% | 0.00% | – |
Q2 2020 | $26,000 | +225.0% | 12,912 | +12.6% | 0.00% | – |
Q1 2020 | $8,000 | – | 11,463 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
tru Independence LLC | 500 | $0 | 0.00% |
Renaissance Technologies | 120,269 | $319,000 | 0.00% |
D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |